2018 - PDF . Final Assessment Report, External Comments/Answers and Project Plan for Other Technologies CA MammaPrint®

This is the assessment of the relative effectiveness of MammaPrint® - Added value of using the gene expression signature test MammaPrint® for adjuvant chemotherapy decision-making in early breast cancer.

Find the documentation provided by the authoring team here.